{"id":49800,"date":"2022-10-19T14:03:26","date_gmt":"2022-10-19T12:03:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/charles-river-launches-hemacare-donor-app-to-engage-diverse-donors-and-source-cell-solutions-for-critical-cell-and-gene-therapy-research\/"},"modified":"2022-10-19T14:03:26","modified_gmt":"2022-10-19T12:03:26","slug":"charles-river-launches-hemacare-donor-app-to-engage-diverse-donors-and-source-cell-solutions-for-critical-cell-and-gene-therapy-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/charles-river-launches-hemacare-donor-app-to-engage-diverse-donors-and-source-cell-solutions-for-critical-cell-and-gene-therapy-research\/","title":{"rendered":"Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research"},"content":{"rendered":"
\n

\nCompany aligns HemaCare Donor Center brand to streamline donor experience<\/i>\n<\/p>\n

WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE:CRL) today announced the launch of a new digital donor experience to enhance access to its donor centers in four distinct US geographic markets. Charles River has been a trusted cell products and services provider for leading developers of cutting-edge cell therapies and basic research for more than 40 years through its acquisitions of HemaCare and Cellero (formerly Key Biologics and Astarte Biologics), now formally integrated as Charles River Cell Solutions. Charles River\u2019s donor center locations, branded as HemaCare Donor Centers, are available coast-to-coast with locations in Northridge, CA, Bothell, WA, Memphis, TN and Lowell, MA.\n<\/p>\n

<\/a><\/p>\n

\nThe new digital donor app enables users to pre-qualify for donations, seamlessly self-schedule upcoming collection appointments online, and receive automated personal reminders and donation tips. The application results in significant time savings for both the donor and the HemaCare Donor Center recruitment team, creating end-to-end efficiency. This improved experience allows for increased donor engagement, conversion into recallable donors, and growth of a diverse donor pool to more readily serve our clients.\n<\/p>\n

\nIn conjunction with the launch of the digital donor application, Charles River aligned its donor-facing HemaCare Donor Center brand nationwide, developed social media messaging campaigns to generate awareness on the value and impact of cellular donations, and created a singular donor center website for streamlining the experience for the prospective donor. This alignment will create consistency that builds trust and loyalty among the donor base.\n<\/p>\n

\nDonation Process<\/b>\n<\/p>\n

\nHemaCare Donor Centers are FDA-registered, AABB-certified, and state-licensed, working with local donors to contribute critical material to support medical breakthroughs. HemaCare Donor Center locations process a variety of blood products including whole blood, bone marrow, white blood cells (apheresis) and mobilized white blood cells. These cells are collected and used in scientific research, drug development, and manufacturing worldwide for cell therapies. All donations involve complete anonymity, and donors receive compensation for their time.\n<\/p>\n

\nCombined with Charles River\u2019s integrated, early-stage portfolio of research models, discovery, safety assessment and CDMO cell and gene therapy manufacturing services, the Company\u2019s cell solutions services<\/a> provides a trusted portfolio of fresh and cryopreserved research use, clinical grade, and GMP-compliant cellular products and consultative guidance along with cell processing and isolation services, creating clear pathways for client cell therapy or basic research goals.\n<\/p>\n

\nApproved Quotes<\/b>\n<\/p>\n